Exhibit 107

Calculation of Filing Fee Table

FORM S-1

(Form Type)

Qualigen Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation Rate			Amount Registered		Proposed Maximum Offering Price Per Unit		Maximum Aggregate Offering Price (1)			Fee Rate		Amount of Registration Fee
Fees to be paid	Equity	Common Stock (2)		457	(o)		-		-	$	12,000,00.00			0.00011020	$	1,322.40
Fees to be Paid	Equity	Pre-Funded Warrants		457	(g)		-		-			(3)		-		-
Fees to be Paid	Equity	Common Stock Warrants		457	(g)		-		-			(3)		-		-
Fees to be Paid	Equity	Common Stock issuable upon exercise of Pre-Funded Warrants (2)		457	(o)		-		-			(4)		-		-
Fees to be Paid	Equity	Common Stock issuable upon exercise of Common Stock Warrants (2)		457	(o)		-		-	$	12,000,000.00			0.00011020	$	1,322.40
		Total Offering Amount								$	24,000,000.00				$	2,644.80
		Total Fees Previously Paid														-
		Total Fee Offsets														-
		Net Fee Due													$	2,644.80

(1)	Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
(2)	Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions.
(3)	Pursuant to Rule 457(g) under the Securities Act, no separate registration fee is required for the warrants.
(4)	The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants sold in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $12,000,000.